Title: Chemist, Professor Emeritus
Company: Department of Drug Design and Pharmacology at the University of Copenhagen
Location: Nivå, Denmark
Søren Brøgger Christensen, Ph.D., Chemist, Professor Emeritus at the University of Copenhagen, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in pharmaceutical sciences.
Dr. Christensen was inspired to enter his profession due to his interest in pharmacy from a young age as a student in pharmacy school. He was interested in researching natural products as sources for new varieties of drugs to aid in health and wellness. He attended the Royal Danish School of Pharmacy (which merged with the University of Copenhagen in 1999), earning a Master of Pharmacy and Doctor of Philosophy in 1971 and 1975, respectively. Upon graduating, he was hired by the school as a research associate to assistant professor, later ascending to the role of associate professor in 1977. From 1993 to 1996, he served as chairman of the department of medicinal chemistry. Since 2016, he has been professor emeritus at the Department of Drug Design and Pharmacology, University of Copenhagen.
Since 1990, Dr. Christensen has been an appointed censor at the Technical University of Denmark, where he focuses his research on natural products chemistry and product development. Notably, he was the co-inventor of Mipsagargin, an anti-cancer drug consisting of the natural plant-derived cytotoxin thapsigargin tailored to attack only solid tumor vasculature. After clinical trials, it was concluded that there was strong evidence to support that it killed whole tumors with few side effects when tested on patients with liver cancer. He also holds a number of patents in the field.
A contributor of articles to professional journals, Dr. Christensen has also been a successful editor, serving on the boards of “New Leads and Targets in Drug Research” in 1992 and “Natural Products and Drug Development” in 1984. He has received several grants from such entities as the Alfred Benzon Foundation, the Danish Cancer Society, the Carlsberg Foundation and Lundbeckfonden. In addition, he was head of SPOTLight in relation to the Danish Strategic Research Council and was a visiting professor at the University of California, Los Angeles, in 1974.
Dr. Christensen is a former honorary fellow of the University College London, and he maintains membership with several industry-related organizations, such as the Danish Chemical Society, the American Chemical Society and the Danish Natural Sciences Academy. In recognition of his exceptional contributions to drug development, he was highlighted in the second edition of Who’s Who in Science and Engineering, as well as three different editions of Who’s Who in the World.
Contact Dr. Christensen